Ardelyx, Inc. (ARDX) financial statements (2020 and earlier)

Company profile

Business Address 34175 ARDENWOOD BLVD.
FREMONT, CA 94555
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:104168134201107107
Cash and cash equivalents93797575107107
Short-term investments118959126  
Other undisclosed cash, cash equivalents, and short-term investments(0)000  
Receivables     3
Other undisclosed current assets7816351
Total current assets:111176150204112111
Noncurrent Assets
Operating lease, right-of-use asset4
Property, plant and equipment468952
Restricted cash and investments    00
Other noncurrent assets010000
Total noncurrent assets:978952
TOTAL ASSETS:119183158213117113
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities51718955
Accounts payable314633
Accrued liabilities 1311   
Employee-related liabilities333322
Debt3     
Deferred revenue and credits   16
Other liabilities0  1  
Other undisclosed current liabilities101 1031
Total current liabilities:18181819822
Noncurrent Liabilities
Long-term debt and lease obligation5349    
Long-term debt, excluding current maturities5049    
Operating lease, liability3
Liabilities, other than long-term debt   1031
Deferred revenue and credits   31
Other liabilities   100
Other undisclosed noncurrent liabilities (49)1   
Total noncurrent liabilities:53111031
Other undisclosed liabilities 49    
Total liabilities:70681920853
Stockholders' equity
Stockholders' equity attributable to parent4911613919310961
Common stock000000
Additional paid in capital490481418407210133
Accumulated other comprehensive income (loss)0(0)(0)(0)  
Accumulated deficit(441)(366)(278)(214)(101)(72)
Total stockholders' equity:4911613919310961
TOTAL LIABILITIES AND EQUITY:119183158213117113

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues3342 2432
Revenue, net42 2432
Cost of revenue(1)(0)(8)(0)(0)(0)
Financial services costs(0)(0)(0)(0)(0)
Gross profit:3234(0)2432
Operating expenses(102)(93)(99)(113)(53)(33)
Other undisclosed operating income   000
Operating loss:(100)(91)(65)(113)(29)(2)
Nonoperating income (expense)5321(0)0
Other nonoperating income (expense)2   (0)0
Interest and debt expense(8)(4)(0)(0)(0) 
Loss from continuing operations before equity method investments, income taxes:(103)(91)(64)(113)(30)(2)
Other undisclosed income (loss) from continuing operations before income taxes(0) 000(2)
Loss from continuing operations before income taxes:(103)(91)(63)(112)(30)(3)
Income tax expense (benefit)(0)(0)(1) 0(0)
Net loss available to common stockholders, diluted:(103)(91)(64)(112)(30)(3)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(103)(91)(64)(112)(30)(3)
Comprehensive loss:(103)(91)(64)(112)(30)(3)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent000(0)  
Comprehensive loss, net of tax, attributable to parent:(103)(91)(64)(112)(30)(3)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: